| 2025年中报 | 2025年一季报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|---|
| 营业收入(元) | ||||||
| 铝镁匹林片(II)(元) | 231,698,207.16 | 85,738,289.81 | - | 194,011,571.99 | 307,210,923.97 | 139,775,726.95 |
| 银杏叶胶囊(元) | 9,686,352.61 | 4,844,077.35 | 18,612,421.40 | 9,161,065.60 | 19,617,901.15 | 8,797,667.94 |
| 技术使用费(元) | - | - | - | 1,089,369.01 | - | - |
| 医药研发(元) | - | - | - | 84,905.66 | - | - |
| 铝镁匹林片(Ⅱ)(元) | - | - | 406,018,322.64 | - | - | - |
| 通心舒胶囊(元) | 8,946,629.90 | - | - | - | - | - |
| 其他产品(元) | 1,061,314.93 | 3,440,286.70 | 16,663,774.85 | 7,174,535.50 | 14,487,391.43 | 7,764,123.77 |
| 营业成本(元) | ||||||
| 铝镁匹林片(II)(元) | 11,873,181.00 | 5,407,841.38 | - | 8,574,198.70 | 13,429,421.27 | 5,921,703.30 |
| 银杏叶胶囊(元) | 3,106,021.44 | 1,508,340.41 | 5,267,177.97 | 2,385,460.76 | 4,226,320.86 | 1,722,331.49 |
| 技术使用费(元) | - | - | - | 1,425,038.76 | - | - |
| 医药研发(元) | - | - | - | 68,409.34 | - | - |
| 铝镁匹林片(Ⅱ)(元) | - | - | 19,496,512.98 | - | - | - |
| 通心舒胶囊(元) | 1,636,993.64 | - | - | - | - | - |
| 其他产品(元) | 769,934.27 | 767,234.07 | 3,140,852.90 | 1,240,489.47 | 2,804,678.03 | 1,583,876.06 |
| 毛利(元) | ||||||
| 铝镁匹林片(II)(元) | 219,825,026.16 | 80,330,448.43 | - | 185,437,373.29 | 293,781,502.70 | 133,854,023.65 |
| 银杏叶胶囊(元) | 6,580,331.17 | 3,335,736.94 | 13,345,243.43 | 6,775,604.84 | 15,391,580.29 | 7,075,336.45 |
| 技术使用费(元) | - | - | - | -335,669.75 | - | - |
| 医药研发(元) | - | - | - | 16,496.32 | - | - |
| 铝镁匹林片(Ⅱ)(元) | - | - | 386,521,809.66 | - | - | - |
| 通心舒胶囊(元) | 7,309,636.26 | - | - | - | - | - |
| 其他产品(元) | 291,380.66 | 2,673,052.63 | 13,522,921.95 | 5,934,046.03 | 11,682,713.40 | 6,180,247.71 |
| 毛利率(%) | ||||||
| 铝镁匹林片(II)(%) | 94.88 | 93.69 | - | 95.58 | 95.63 | 95.76 |
| 银杏叶胶囊(%) | 67.93 | 68.86 | 71.70 | 73.96 | 78.46 | 80.42 |
| 技术使用费(%) | - | - | - | -30.81 | - | - |
| 医药研发(%) | - | - | - | 19.43 | - | - |
| 铝镁匹林片(Ⅱ)(%) | - | - | 95.20 | - | - | - |
| 通心舒胶囊(%) | 81.70 | - | - | - | - | - |
| 其他产品(%) | 27.45 | 77.70 | 81.15 | 82.71 | 80.64 | 79.60 |
| 收入构成(%) | ||||||
| 铝镁匹林片(II)(%) | 92.17 | 91.19 | - | 91.72 | 90.01 | 89.41 |
| 银杏叶胶囊(%) | 3.85 | 5.15 | 4.22 | 4.33 | 5.75 | 5.63 |
| 技术使用费(%) | - | - | - | 0.52 | - | - |
| 医药研发(%) | - | - | - | 0.04 | - | - |
| 铝镁匹林片(Ⅱ)(%) | - | - | 92.01 | - | - | - |
| 通心舒胶囊(%) | 3.56 | - | - | - | - | - |
| 其他产品(%) | 0.42 | 3.66 | 3.78 | 3.39 | 4.24 | 4.97 |
| 毛利构成(%) | ||||||
| 铝镁匹林片(II)(%) | 93.94 | 93.04 | - | 93.74 | 91.56 | 90.99 |
| 银杏叶胶囊(%) | 2.81 | 3.86 | 3.23 | 3.43 | 4.80 | 4.81 |
| 技术使用费(%) | - | - | - | -0.17 | - | - |
| 医药研发(%) | - | - | - | 0.01 | - | - |
| 铝镁匹林片(Ⅱ)(%) | - | - | 93.50 | - | - | - |
| 通心舒胶囊(%) | 3.12 | - | - | - | - | - |
| 其他产品(%) | 0.12 | 3.10 | 3.27 | 3.00 | 3.64 | 4.20 |